Screener
MapLight Therapeutics, Inc. MPLT Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:25 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224129
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(60,668) | $(22,340) |
| Net loss per share - basic and diluted | $(1.34) | $(29.33) |
| Weighted-average number of common shares outstanding - basic and diluted | 45,276,763 | 761,598 |
| Comprehensive loss: | ||
| Net loss | $(60,668) | $(22,340) |
| Other comprehensive loss: | ||
| Unrealized loss on available-for-sale investments | (655) | (78) |
| Comprehensive loss | $(61,323) | $(22,418) |
Item 1. Financial Statements.
FAQ
- What is MapLight Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- MapLight Therapeutics, Inc. (MPLT) reported comprehensive income (loss), net of tax, attributable to parent of -$61.32M in Q1 2026.
- How has MapLight Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- MapLight Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 173.5% year-over-year, from -$22.42M to -$61.32M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance by including all recognized revenues, expenses, gains, and losses. Investors use this to evaluate the total impact of all financial activities on the company's net worth.
Ask your AI about MapLight Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude